Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Dykstra

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Pharmacology and Therapeutics|October 21, 2021
Exposure-Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation RecipientsMarita Prohn, Carolyn R Cho, Anders Viberg, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2019
Development of indazole mineralocorticoid receptor antagonists and investigation into their selective late-stage functionalizationKun Liu, Ravi Kurukulasuriya, Kevin Dykstra, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsRajesh Krishna, Amit Garg, Deborah Panebianco, et al.
Journal of Medicinal Chemistry|March 3, 2017
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 InhibitorsTim Cernak, Nathan J Gesmundo, Kevin Dykstra, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Pharmacology and Therapeutics|October 21, 2021
Exposure-Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation RecipientsMarita Prohn, Carolyn R Cho, Anders Viberg, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2019
Development of indazole mineralocorticoid receptor antagonists and investigation into their selective late-stage functionalizationKun Liu, Ravi Kurukulasuriya, Kevin Dykstra, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsRajesh Krishna, Amit Garg, Deborah Panebianco, et al.
Journal of Medicinal Chemistry|March 3, 2017
Microscale High-Throughput Experimentation as an Enabling Technology in Drug Discovery: Application in the Discovery of (Piperidinyl)pyridinyl-1H-benzimidazole Diacylglycerol Acyltransferase 1 InhibitorsTim Cernak, Nathan J Gesmundo, Kevin Dykstra, et al.
Pageof 2